Clinical Trial: GORE TAG® Thoracic Endoprosthesis - 45 mm for the Treatment of Aneurysms of the Descending Thoracic Aorta
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Evaluation of the GORE TAG® Thoracic Endoprosthesis - 45 mm for the Primary Treatment of Aneurysms of the Descending Thoracic Aorta
Brief Summary: The objective of this study is to assess the safety and efficacy of the 45 mm TAG device in subjects with aneurysms of the descending thoracic aorta.
Detailed Summary:
Sponsor: W.L.Gore & Associates
Current Primary Outcome: Freedom From Major Adverse Events and Major Device Events Through 1 Year Post-treatment [ Time Frame: one year ]
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: W.L.Gore & Associates
Dates:
Date Received: December 20, 2007
Date Started: February 2007
Date Completion:
Last Updated: March 4, 2015
Last Verified: March 2015